Literature DB >> 8258653

Multiple pituitary hormone deficiencies in a patient with spinocerebellar ataxia: magnetic resonance imaging and hormonal studies.

E Bhatia1, R Shukla, R K Gupta, U K Misra.   

Abstract

Degenerative spinocerebellar ataxia has a rare association with hypogonadotropic hypogonadism. In this report we present the results of the detailed endocrine evaluation and magnetic resonance imaging in one such patient. A 20-year-old male with progressive cerebellar ataxia, hypogonadism, and short stature was investigated. Basal testing revealed hypogonadotropic hypogonadism (LH < 5 mU/L, FSH < 5 mU/L, testosterone 2.5 nM/L). There was no rise in LH after stimulation with LHRH, peak LH level being < 5 mU/L. Insulin hypoglycemia testing was consistent with GH deficiency, with peak GH being 3.2 mU/L. On TRH stimulation, there was no significant rise in prolactin, though the TSH response was normal. Magnetic resonance imaging revealed cerebellar atrophy. The anterior pituitary was atrophic, with a height of 1.4 mm. The posterior pituitary and the pituitary stalk were normal in size and position. This patient with degenerative spinocerebellar ataxia had multiple pituitary hormone deficiencies. The results of our endocrine evaluation and MR imaging lead us to believe that these deficits may result from a lesion at the level of the pituitary gland.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258653     DOI: 10.1007/BF03347686

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Familial ataxia, hypogonadism and retinal degeneration.

Authors:  B J Boucher; F B Gibberd
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

2.  X-linked recessive hypopituitarism.

Authors:  P D Phelan; J Connelly; F I Martin; H N Wettenhall
Journal:  Birth Defects Orig Artic Ser       Date:  1971-05

3.  Cerebellar ataxia and hypogonadism. A clinicopathological report.

Authors:  G De Michele; A Filla; F P D'Armiento; S Striano; F Barbieri; G Salvatore; V Di Carlo; D Mansi
Journal:  Clin Neurol Neurosurg       Date:  1990       Impact factor: 1.876

4.  The Friedreich ataxia gene is assigned to chromosome 9q13-q21 by mapping of tightly linked markers and shows linkage disequilibrium with D9S15.

Authors:  A Hanauer; M Chery; R Fujita; A J Driesel; S Gilgenkrantz; J L Mandel
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

5.  Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features.

Authors:  A E Harding
Journal:  Brain       Date:  1981-09       Impact factor: 13.501

6.  Posterior pituitary ectopia: an MR feature of pituitary dwarfism.

Authors:  W M Kelly; W Kucharczyk; J Kucharczyk; B Kjos; W W Peck; D Norman; T H Newton
Journal:  AJNR Am J Neuroradiol       Date:  1988 May-Jun       Impact factor: 3.825

7.  Hypothalamic-pituitary function in growth hormone-deficient patients with pituitary stalk transection.

Authors:  K Kikuchi; I Fujisawa; T Momoi; C Yamanaka; M Kaji; Y Nakano; J Konishi; H Mikawa; M Sudo
Journal:  J Clin Endocrinol Metab       Date:  1988-10       Impact factor: 5.958

8.  Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.

Authors:  T P Foley; L S Jacobs; W Hoffman; W H Daughaday; R M Blizzard
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

9.  Idiopathic growth hormone deficiency: MR findings in 35 patients.

Authors:  J J Abrahams; E Trefelner; S D Boulware
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jan-Feb       Impact factor: 3.825

10.  Hypothalamo-pituitary axis by magnetic resonance imaging in isolated growth hormone deficiency patients born by normal delivery.

Authors:  R Marwaha; P S Menon; A Jena; C Pant; A K Sethi; M L Sapra
Journal:  J Clin Endocrinol Metab       Date:  1992-03       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.